Group recommends targeting CER for priority populations
This article was originally published in The Tan Sheet
Executive Summary
Federal agencies should target comparative effectiveness research funds for studies involving racial and ethnic minorities, children, women, the elderly and people with multiple chronic conditions, the Brookings Institution's Engelberg Center for Health Care Reform says. The center's draft report recommends government organizations that support CER "allocate research funds to meritorious investigator-initiated proposals that are responsive to priority populations, and create targeted funding opportunities to fill gaps." The health care reform Congress enacted in March requires CER and gives oversight to a federal institute operating in a public/private partnership mode (1"The Tan Sheet" April 19, 2010). The draft notes research does not focus enough on conditions that affect priority populations, and priority populations typically are not recruited for trials. Another problem is the clinical trials infrastructure is not set up to allow for more participation from members of priority groups
You may also be interested in...
Comparative Effectiveness Could Take A Close Look At CAM - Sebelius
Comparative effectiveness research required under health care reform likely will be used to carefully test the value of complementary and alternative medicines rather than simply hold up those products as less-expensive alternatives to pharmaceuticals
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.